Patient-derived iPSCs to study blood cancer
Nat Rev Cancer
.
2023 Nov;23(11):727.
doi: 10.1038/s41568-023-00617-y.
Author
Emmanuel Olivier
1
Affiliation
1
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. emmanuel.olivier@mssm.edu.
PMID:
37700199
DOI:
10.1038/s41568-023-00617-y
No abstract available
MeSH terms
Cell Differentiation
Hematologic Neoplasms*
Humans
Induced Pluripotent Stem Cells*
Neoplasms* / genetics
Neoplasms* / therapy